DrugPatentWatch Database Preview
Sunovion Pharms Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for SUNOVION PHARMS INC, and what generic alternatives to SUNOVION PHARMS INC drugs are available?
SUNOVION PHARMS INC has five approved drugs.
There are thirty-four US patents protecting SUNOVION PHARMS INC drugs.
There are four hundred and one patent family members on SUNOVION PHARMS INC drugs in thirty-six countries and twenty-five supplementary protection certificates in sixteen countries.
Summary for Sunovion Pharms Inc
| International Patents: | 401 |
| US Patents: | 34 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Sunovion Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunovion Pharms Inc | APTIOM | eslicarbazepine acetate | TABLET;ORAL | 022416-003 | Nov 8, 2013 | RX | Yes | No | 9,643,929 | Start Trial | Y | Start Trial | |||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-002 | Oct 28, 2010 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-001 | Oct 28, 2010 | AB | RX | Yes | Yes | 8,883,794*PED | Start Trial | Y | Start Trial | ||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-003 | Dec 7, 2011 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sunovion Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-004 | Apr 26, 2012 | 5,532,372*PED | Start Trial |
| Sunovion Pharms Inc | LUNESTA | eszopiclone | TABLET;ORAL | 021476-001 | Dec 15, 2004 | 6,444,673*PED | Start Trial |
| Sunovion Pharms Inc | LUNESTA | eszopiclone | TABLET;ORAL | 021476-002 | Dec 15, 2004 | 6,319,926*PED | Start Trial |
| Sunovion Pharms Inc | LUNESTA | eszopiclone | TABLET;ORAL | 021476-001 | Dec 15, 2004 | 6,864,257*PED | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUNOVION PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg | ➤ Subscribe | 2014-10-28 |
| ➤ Subscribe | Tablets | 1 mg, 2 mg and 3 mg | ➤ Subscribe | 2008-12-15 |
International Patents for Sunovion Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | 112015023725 | Start Trial |
| Spain | 2408687 | Start Trial |
| China | 105491997 | Start Trial |
| Turkey | 9701734 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sunovion Pharms Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0751129 | SPC/GB09/047 | United Kingdom | Start Trial | PRODUCT NAME: ESLICARBAZEPINE ACETATE; REGISTERED: UK EU/1/09/514/001 20090421; UK EU/1/09/514/002 20090421; UK EU/1/09/514/003 20090421; UK EU/1/09/514/004 20090421; UK EU/1/09/514/005 20090421; UK EU/1/09/514/006 20090421; UK EU/1/09/514/019 20090421; UK EU/1/09/514/020 20090421; UK EU/1/09/514/013 20090421; UK EU/1/09/514/014 20090421; UK EU/1/09/514/015 20090421; UK EU/1/09/514/016 20090421; UK EU/1/09/514/017 20090421; UK EU/1/09/514/018 20090421; UK EU/1/09/514/007 20090421; UK EU/1/09/514/008 20090421; UK EU/1/09/514/009 20090421; UK EU/1/09/514/010 20090421; UK EU/1/09/514/011 20090421; UK EU/1/09/514/012 20090421 |
| 1884242 | CR 2014 00049 | Denmark | Start Trial | PRODUCT NAME: LURASIDON HYDROCHLORID; REG. NO/DATE: EU/1/14/913/001-021 20140327 |
| 1884242 | C01884242/01 | Switzerland | Start Trial | PRODUCT NAME: LURASIDON; REGISTRATION NO/DATE: SWISSMEDIC 62785 12.08.2013 |
| 0751129 | 360 | Finland | Start Trial | |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
